AirECMO and REVA Launch Cooperation

AirECMO

AirECMO, Inc., a division of Keystone Perfusion Services, P.C. announces a strategic partnership with industry leading air ambulance provider, REVA, to provide ECMO transportation capabilities globally. ECMO is an extracorporeal technique of providing prolonged cardiac and respiratory support to persons whose heart and lungs are unable to maintain hemodynamic stability.

Cardiovascular devices lead FDA Breakthrough Device Designation program

The Harmony pulmonary valve was among the devices involved with the FDA Breakthrough Device Designation program that gained more rapid market clearance. The FDA graph shows cardiovascular devices leading the types of devices involved in the program.
The Harmony pulmonary valve was among the devices involved with the FDA Breakthrough Device Designation program that gained more rapid market clearance. The FDA graph shows cardiovascular devices leading the types of devices involved in the program.

The FDA said cardiovascular devices make up the largest number of technologies accepted into the Breakthrough Devices Program, and several are on the list of the first 50 in the program to gain market clearance.

VIDEO: New Technologies in Cardiac CT Imaging

Fat attenuation index (FAI) CT imaging of coronary artery fat can show inflammation and can help pin-point vulnerable plaques, or show the reversal of inflammation due to drug therapies. The technology is being developed by the vendor Caristo, which has European CE mark and the company is seeking FDA clearance. #SCCT #SCCT2022

Fat attenuation index (FAI) CT imaging of the fat surrounding coronary arteries can show inflammation in the vessel wall and help pin-point vulnerable plaques. This also can show the reversal of inflammation due to drug therapies. The technology is being developed by the vendor Caristo, which has European CE mark and the company is seeking FDA clearance.

Ron Blankstein, MD, Brigham and Women's Hospital, explains recent advances in coronary computed tomography angiography (CCTA) technology. 

Cardiac CT now in the spotlight thanks to chest pain guidelines

With the elevation of cardiac CT to a 1A indication in the 2021 Chest Pain Guidelines, there has been a large amount of interest in starting coronary artery CT angiography (CCTA) programs.